Acute myocardial infarction mortality in Chile. Thrombolysis or angioplasty

作者：Florenzano U Fernando

来源：Revista Medica de Chile, 2011, 139(11): 1393-1395.

DOI：10.4067/S0034-98872011001100001

• Mortality
• Myocardial infarction
• Myocardial reperfusion
• Thrombolytic therapy

During recent decades, acute myocardial infarction short-term mortality has decreased to one digit levels, in the United States. Data from Chilean registries give figures around 11% for patients receiving thrombolysis, and 5 to 6 % for patients treated with angioplasty. The decrease in mortality in Chile is related to the implementation of the AUGE program at a national level, initiative than gives patients the opportunity to receive at least thrombolytic therapy as well as a standardized and rapid diagnosis and treatment for this condition. There is a lack of Outcome Research studies in Chile, that would guide public health decisions such as the use of fibrin-specific agents for early presentation and high risk cases, and a rational system providing better access to primary angioplasty. (Rev Med Chile 2011; 139: 1393-1395).

• 出版日期2011-11